期刊文献+

甲基莲心碱脂质体的研制及其体外释药考察 被引量:2

Study on the Preparation and Drug Release of Neferine Liposomes in Vitro
原文传递
导出
摘要 目的:研制甲基莲心碱脂质体,并对其体外性质进行考察。方法:采用薄膜分散法制备脂质体,利用正交实验对其处方进行优化对其形态、粒径、包封率及释药等体外性质进行考察。结果:甲基莲心碱脂质体形态规整,平均粒径为(842.5±4.65)nm,平均包封率为(72.8±1.5)%体外释药遵循Higuchi方程:Q=30.78t_(1/2)-5.12,(R^2=0.995),具有明显的缓释效果。结论:优化得到甲基莲心碱脂质体的处方及制备工艺,为进一步体内研究奠定了基础。 Objective: To study the preparation of neferine liposomes and drug release in vitro. Method: Neferine liposomes was prepared by film dispersion method. The formulation was screened by orthonogonal test and the appearance, mean size, encapsulation rate (ER%) and drug release in vitro were studied. Result: The shape of neferine liposomes was spherical with mean diameter of (842. 5 ±4. 65) nm and ER% of (72. 8 ± 1.5 ) %. Drug release rate was accorded with Higuchi equation of Q = 30. 78t1/2 - 5.12, ( R2 = 0. 995 ), showed significant sustained release property. Conclusion: The optimal formulation and preparation process of neferine liposomes was the basis of further study in vivo.
作者 杨淑清
出处 《中国药师》 CAS 2010年第9期1255-1257,共3页 China Pharmacist
关键词 甲基莲心碱 脂质体 制备 体外释药 Neferine Lliposomes Preparation Drug release in vitro
  • 相关文献

参考文献5

二级参考文献32

  • 1曾繁忠.有机磷农药中毒的解毒药物应用[J].中华内科杂志,1993,32(12):838-839. 被引量:46
  • 2喻晶,胡文淑.甲基莲心碱对血小板聚集和胞浆游离钙离子浓度的影响[J].中国药理学与毒理学杂志,1996,10(2):120-122. 被引量:14
  • 3陈剑雄,曾恒,唐小卿.光化学诱导大脑中动脉栓塞后脑组织中水、阳离子及脂质过氧化产物含量的变化[J].衡阳医学院学报,1996,24(4):262-264. 被引量:3
  • 4孙艳翎,王毅,郝建华,徐永生,马献图,曾小林,牛敏,王迎春.有机磷农药中毒的抗毒药物的应用探讨[J].工业卫生与职业病,1996,22(3):180-181. 被引量:2
  • 5Ran S , He J , Huang XM , et al. Antitumor effects of a monoclonal antiboby that binds anionic phospholipids on the surface of tumor blood vessels in mice [ J ]. Clinical Cancer Research, 2005,11 : 1151-1162.
  • 6Mounkes LC, Zhong W, Cipres-Palacin G, et al. Proteoglyeans mediate cationic liposome-DNA complex-based gene deliver), in vitro and in vivo [ J ]. Biol Chern , 1998,273:26164-26170.
  • 7Augustin HG , Kozian DH , Johson RC. Differentiation of endothelial cells : analysis of the constructive and activated endothelial cells phenotypes [ J ]. Bioessays, 1994,16:901-906.
  • 8Kunsffeld R , Wickenhauser G , Michaelis U , et al. Paclitaxe encapsulated in cati-onie liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model [ J ]. Invest Dermatol, 2003,120:476-482.
  • 9Strieth S , Eichhorn ME , Sauer B , et al. Neovascular targeting chemotherapy : encapsulation of paclitaxe in cationic liposomes impair functional tumor microvascu lature [ J ]. Int J Cancer, 2004,110 : 117-124.
  • 10Sandri G, Rossi S, Bonferoni MC, et al. Buccal penetration enhancement properties of N-trimethyl chitosan : Influence of quaternization deggre on absorption of a high molecular weight molecule [ J ]. Intemizational Journal of Pharmaceutics ,2005,297 : 146-155.

共引文献39

同被引文献33

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部